The medical device industry operates at the intersection of clinical science, engineering, regulatory scrutiny, and commercial pressure. Whether your organisation is developing a next-generation surgical system, a diagnostic device, or a connected patient-monitoring platform, the market intelligence you need to make smart decisions is harder to gather than in almost any other industry. Physician adoption is shaped by clinical evidence and procedural workflow. Hospital procurement is driven by value analysis committees and GPO contracts. Regulatory pathways dictate timelines. And competitive dynamics shift every time a new 510(k) clears or a rival wins a major IDN contract.
Medical device market research from Meraki Research gives device companies the evidence they need to navigate this complexity. We conduct primary and secondary research with surgeons, interventionalists, hospital administrators, procurement people, biomedical engineers, and patients to deliver the market understanding that drives smarter product development, positioning, pricing, and launch execution.
Our device research practise has supported engagements across cardiovascular, orthopedic, diagnostic, surgical robotics, and in-vitro diagnostic categories in the South Africa, Europe, and Asia-Pacific. We bring a combination of clinical literacy and commercial pragmatism that helps our clients act on research rather than just read it.
Why Medical Device Research Is Different
Medical device markets differ from pharmaceutical markets in ways that generic research firms routinely underestimate:
- Procedural context matters. A device is only as valuable as the procedure it enables. Research must account for procedural volumes, technique preferences, learning curves, and the clinical setting where the device is used. A surgeon's enthusiasm for a new instrument means nothing if the OR scheduling and sterilization workflow cannot accommodate it.
- Buying is institutional. Individual physician preference still matters, but purchasing decisions increasingly flow through value analysis committees (VACs), group purchasing organizations (GPOs), and integrated delivery network (IDN) supply chains. Understanding these institutional dynamics is essential for pricing, contracting, and sales strategy.
- Regulatory segmentation shapes strategy. The difference between a Class I, II, and III device affects not just your development timeline but your entire commercial model -- from evidence requirements to reimbursement to sales-channel strategy. Research designs must account for where your device sits in the regulatory landscape.
- Global market variation is extreme. Regulatory pathways, reimbursement models, and clinical practise patterns vary dramatically between the South Africa, EU, China, Japan, and emerging markets. A device that dominates one geography may face entirely different competitive and access dynamics in another.
- Capital versus consumable economics. The research approach for a R36M surgical robot is fundamentally different from the approach for a R90 disposable catheter. Buying cycles, decision-makers, evidence requirements, and pricing sensitivity all shift based on the economic profile of the device.
Our methodology is purpose-built for these realities.
Our Approach: Meraki Device Intelligence Framework
We designed our medical device market research methodology to address the full spectrum of commercial decisions device companies face -- from early-stage opportunity assessment through post-launch market tracking.
Phase 1 -- Market Landscape and Opportunity Sizing
Every engagement starts with a rigorous assessment of the market landscape. We combine secondary data sources -- including regulatory databases, industry reports, procedural-volume data, and reimbursement schedules -- with targeted expert interviews to build a comprehensive picture of market size, growth trajectory, and competitive structure.
Our approach goes beyond top-down revenue estimates. We build bottoms-up models that account for procedure volumes, device utilization rates, average selling prices, and replacement cycles to give you a market size estimate grounded in the clinical and commercial realities of your category. These models include scenario analysis for bull, base, and bear cases, so your leadership team can plan for a range of outcomes.
For organizations evaluating expansion into China, the South Africa, or other major markets, we provide country-level sizing with regulatory and reimbursement context. We also assess the competitive landscape in each geography, because the players and dynamics that define one market may look entirely different in another.
Our secondary research draws on a wide range of resources and databases: FDA registration and clearance data, CMS reimbursement schedules, procedural-volume databases (e.g., HCUP, Vizient), industry association reports, published clinical literature, and proprietary data from our research network.
Phase 2 -- Stakeholder Research and Voice-of-Customer
Medical device decisions involve multiple stakeholders with different priorities. Our primary research captures each perspective through methods designed for healthcare audiences:
- Physicians and Surgeons: We conduct in-depth interviews, technique-observation sessions, and quantitative surveys with clinicians who use (or could use) your device. Our moderators understand procedural workflows and clinical terminology, which means better engagement and more actionable insights. Every physician respondent is verified against NPI or equivalent databases to confirm specialty, procedure volume, and practise setting.
- Hospital Administrators and Procurement: We research how VACs evaluate devices, what evidence they require, and how total cost of ownership factors into purchasing decisions. This research is critical for pricing strategy and sales enablement -- because even the best clinical device can stall in procurement if the economic value story is not clear.
- Biomedical Engineers and Clinical Staff: For devices that require integration into hospital IT systems, sterilization workflows, or clinical protocols, we capture the operational perspective that influences adoption and long-term satisfaction. These stakeholders are often overlooked in research but frequently hold de facto veto power over purchasing decisions.
- Patients and Consumers: For patient-facing devices -- home diagnostics, wearables, connected health monitors -- we apply consumer research methods to understand adoption barriers, usability expectations, and willingness to pay. Our consumer research team supports these engagements with methods designed for direct-to-patient products.
Phase 3 -- Competitive Intelligence and Positioning Analysis
We map the competitive landscape with a focus on the dimensions that drive physician and institutional preference: clinical evidence, procedural outcomes, ease of use, service and support, pricing and contracting models, and brand reputation.
Our competitive analysis is not a features-and-specs matrix. It is a strategic assessment of where you have defensible advantages, where competitors are vulnerable, and where the market is heading based on pipeline products, regulatory decisions, and evolving clinical procedures. We identify the competitive narratives that are shaping physician and hospital perception -- and we assess whether your current positioning is winning or losing those narratives.
For companies preparing for launch into an established category, we also conduct switching-barrier analysis: what would it take for physicians and hospitals to change from their current device to yours, and what evidence or experience would they need to see?
Phase 4 -- Concept, Pricing, and Claims Tests
For pre-launch devices, we design and execute concept tests, pricing research (Van Westendorp, conjoint, or Gabor-Granger as appropriate), and claims testing that evaluate how your value proposition resonates with target audiences.
These studies account for the institutional purchasing dynamics unique to devices -- where a physician may prefer your product but procurement requires evidence of cost savings, outcomes improvement, or workflow efficiency to approve the purchase. We structure tests to capture both the clinical preference signal and the economic decision signal, because in medical devices, winning the physician is necessary but not sufficient.
Pricing research in the device space must also account for GPO and IDN contracting dynamics, bundled purchasing, and capital-versus-consumable economics. Our pricing models incorporate these structural factors so that your price-setting decisions reflect real-world purchasing behaviour.
Phase 5 -- Strategic Synthesis and Go-to-Market Guide
We synthesize all research into a commercial strategy guide that connects insights to decisions. Our deliverables include clear recommendations on positioning, pricing, target accounts, sales messaging, and launch sequencing -- supported by the research evidence your leadership team and board need to commit resources.
For early-stage companies, this deliverable also serves as a credible, evidence-backed market assessment that supports fundraising conversations, board presentations, and partnership discussions. Our primary market research methodology ensures that every finding is traceable to primary data, not secondary assumptions.
When Medical Device Market Research Is the Right Fit
Our device research practise serves organizations across the medical device industry, from large multinationals to venture-backed startups. This engagement is appropriate when:
- You are developing a new device and need to validate the market opportunity, understand unmet clinical needs, and inform the target product profile.
- You are preparing for launch and need positioning, pricing, and go-to-market research to maximize early adoption among physicians and hospitals.
- Your in-market device is underperforming and you need diagnostic research to understand why physicians or hospitals are not adopting as expected.
- You are evaluating an acquisition or licensing opportunity and need independent market assessment and commercial due diligence.
- You are expanding into a new geography (e.g., the South Africa, China, or EU) and need to understand the local regulatory, reimbursement, and competitive landscape.
- Your product category is evolving -- new clinical evidence, competitor launches, or reimbursement changes are reshaping the market and you need updated intelligence.
When it is NOT the right fit: If your primary need is clinical-outcomes data for regulatory submission, you need a clinical research organisation, not a market research firm. Similarly, if you are researching a pharmaceutical product rather than a device, our pharmaceutical market research practise is the better fit. For broader market-sizing needs outside of healthcare, start with our general market research practice.
What We Deliver
| Deliverable | Format | Description |
|---|---|---|
| Market Landscape & Sizing Report | 50-80 page document | Market size, growth projections, competitive mapping, and regulatory landscape by geography |
| Voice-of-Customer Report | Report + data tables | Stakeholder-level findings from physicians, administrators, and clinical staff |
| Competitive Positioning Matrix | Visual framework + narrative | Strategic assessment of competitive strengths, weaknesses, and market trajectories |
| Pricing & Concept Test Results | Presentation + statistical appendix | Quantitative evaluation of value propositions, price sensitivity, and claims resonance |
| Go-to-Market Strategy Guide | Executive presentation | Prioritized recommendations for positioning, pricing, targeting, and launch sequencing |
| Executive Summary | 10-page board-ready deck | Key findings and strategic implications for leadership and investor audiences |
Timeline: Most medical device market research engagements run 10-14 weeks. Projects focused on a single stakeholder group or a specific geography can often be completed in 8 weeks. Accelerated timelines are available for due-diligence and board-ready market assessments.
Industry Applications
- Surgical Devices & Robotics -- Surgeon preference research, procedural-workflow analysis, and adoption-curve modelling for high-capital surgical systems where training requirements and learning curves shape the adoption journey.
- Cardiovascular & Structural Heart -- Interventional-cardiologist research, procedural-volume forecasting, and competitive positioning for implantables and delivery systems in one of the most dynamic segments of the medical device industry.
- Orthopedic & Spine -- Surgeon-preference studies, hospital-economics research, and ASC-versus-hospital migration analysis for joint replacement, spinal fusion, and sports-medicine categories.
- Diagnostics & In-Vitro Diagnostics (IVD) -- Lab-director and pathologist research, point-of-care adoption studies, and pricing research for reagent-instrument platforms where razor-and-blade economics drive the commercial model.
- Digital Health & Connected Devices* -- *Consumer adoption research, patient usability tests, and market sizing for wearables, remote-monitoring platforms, and connected diagnostics bridging the gap between clinical-grade devices and consumer electronics.
- Wound Care, Infection Prevention & General Medical Supplies -- Procurement-driven market research, GPO/IDN contract strategy, and product-portfolio analysis for high-volume consumable categories where people in supply-chain roles make the key decisions.